Comments: NJ A3668 | 2024-2025 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-02-12 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A3668 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2024 New Jersey A3668 at this time.

Social Comments on NJ A3668

feedback